• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Hypothyrotropin hypothyroidism caused by roxadustat: a case report].

作者信息

Shi X T, Li M, Cui W X, Chen J, Lu Y, Hu Y

机构信息

Department of Geriatrics, Nanjing Drum Tower Hospital Affiliated to Medicine School of Nanjing University, Nanjing 210008, China.

Department of Pharmacy, Nanjing Drum Tower Hospital Affiliated to Medicine School of Nanjing University, Nanjing 210008, China.

出版信息

Zhonghua Nei Ke Za Zhi. 2022 Dec 1;61(12):1357-1359. doi: 10.3760/cma.j.cn112138-20220121-00068.

DOI:10.3760/cma.j.cn112138-20220121-00068
PMID:36456517
Abstract
摘要

相似文献

1
[Hypothyrotropin hypothyroidism caused by roxadustat: a case report].[罗沙司他引起的低促甲状腺素性甲状腺功能减退症：一例报告]
Zhonghua Nei Ke Za Zhi. 2022 Dec 1;61(12):1357-1359. doi: 10.3760/cma.j.cn112138-20220121-00068.
2
A case report of rhabdomyolysis caused by the use of roxadustat in the treatment caused by renal anaemia.罗沙司他治疗肾性贫血引起横纹肌溶解症 1 例报告。
Int J Clin Pract. 2021 Jun;75(6):e14011. doi: 10.1111/ijcp.14011. Epub 2021 Jan 25.
3
Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis.罗沙司他治疗透析患者肾性贫血时抑制促甲状腺激素分泌。
BMC Nephrol. 2021 Mar 20;22(1):104. doi: 10.1186/s12882-021-02304-2.
4
Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease.缺氧诱导因子脯氨酰羟化酶抑制剂罗沙司他的非临床特征：慢性肾脏病贫血的一种新治疗方法。
J Pharmacol Exp Ther. 2020 Aug;374(2):342-353. doi: 10.1124/jpet.120.265181. Epub 2020 Jun 2.
5
Red blood cell lifespan in long-term hemodialysis patients treated with roxadustat or recombinant human erythropoietin.罗沙司他或重组人促红细胞生成素治疗的长期血液透析患者的红细胞寿命。
Ren Fail. 2021 Dec;43(1):1428-1436. doi: 10.1080/0886022X.2021.1988968.
6
Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS).罗沙司他治疗未透析慢性肾脏病患者贫血的 3 期、随机、双盲、安慰剂对照研究（ALPS）。
Nephrol Dial Transplant. 2021 Aug 27;36(9):1629-1639. doi: 10.1093/ndt/gfab057.
7
Effect of the Phosphate Binders Sevelamer Carbonate and Calcium Acetate on the Pharmacokinetics of Roxadustat After Concomitant or Time-separated Administration in Healthy Individuals.碳酸司维拉姆和醋酸钙这两种磷结合剂对罗沙司他在健康个体中联合给药或分时给药后的药代动力学的影响。
Clin Ther. 2021 Jun;43(6):1079-1091. doi: 10.1016/j.clinthera.2021.03.025. Epub 2021 May 5.
8
The efficacy and economic evaluation of roxadustat treatment for anemia in patients with kidney disease not receiving dialysis.罗沙司他治疗未透析肾病患者贫血的疗效和经济评价。
Expert Rev Pharmacoecon Outcomes Res. 2020 Aug;20(4):411-418. doi: 10.1080/14737167.2020.1747436. Epub 2020 Apr 4.
9
Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patients.影响血液透析患者罗沙司他与达贝泊汀治疗贫血剂量的因素。
Ther Apher Dial. 2021 Oct;25(5):575-585. doi: 10.1111/1744-9987.13609. Epub 2020 Dec 15.
10
Effect of Kidney Function and Dialysis on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor.肾功能和透析对罗沙司他（一种口服低氧诱导因子脯氨酰羟化酶抑制剂）的药代动力学和药效学的影响。
Eur J Drug Metab Pharmacokinet. 2021 Jan;46(1):141-153. doi: 10.1007/s13318-020-00658-w.

引用本文的文献

1
Effects of roxadustat on thyroid hormone levels and blood lipid metabolism in patients undergoing hemodialysis: a retrospective study.罗沙司他对血液透析患者甲状腺激素水平和血脂代谢的影响：一项回顾性研究。
Int J Med Sci. 2024 Jul 9;21(10):1806-1813. doi: 10.7150/ijms.97599. eCollection 2024.